12 January 2015Immunocore appoints Dr Eliot Forster as Chief Executive Officer
16 July 2014Immunocore and Lilly Enter Immunotherapy Agreement to Co-Discover and Co-Develop Novel Cancer Therapies
26 March 2014Immunocore announces re-organisation of its executive management to support business growth
14 January 2014Immunocore to present at 32nd Annual JP Morgan Healthcare Conference and to provide an update on lead programme for melanoma
08 January 2014Immunocore and MedImmune enter immunotherapy agreement to develop novel cancer therapies
14 November 2013Immunocore appoints Dr Jonathan Knowles as Chairman of the Board